SCOTUS Urged to Uphold Injunction on Trump Transgender Inmate Healthcare Policy

• Lawyers for transgender inmates urged the Supreme Court to uphold an injunction blocking a new federal prison healthcare policy.
• The contested policy, adopted by the Trump administration, would restrict access to hormone therapy and social accommodations for transgender inmates.
• This policy originated from a February 2025 directive implementing a Trump executive order on federal funding for gender-affirming care.
• The Federal Bureau of Prisons justified its February 2026 policy change by citing "latest scientific information," moving away from WPATH standards.
• The inmates' representative argued the administration seeks to overturn a three-decade-old standard of care for transgender individuals in federal custody.

The Supreme Court's decision will directly influence the scope of medical and social accommodations available to transgender inmates within federal correctional facilities, potentially setting a significant precedent for future cases.

Lawyers representing a group of transgender inmates within the Federal Bureau of Prisons (BOP) recently urged the Supreme Court to maintain a standing order issued by a federal judge in Washington, D.C. This judicial directive currently prevents the BOP from implementing a new healthcare policy that would significantly restrict access to essential medical and social accommodations for transgender individuals in federal custody.

The contested policy specifically targets services such as hormone therapy, which is a critical component of gender-affirming care, as well as various social accommodations including makeup, wigs, and padding. The legal team, led by Li Nowlin-Sohl, argued before the justices that the Trump administration's push to enforce this policy represents an attempt to dismantle a "three decades-long status quo" concerning transgender inmate healthcare.

This development signals ongoing legal challenges to federal correctional policies concerning transgender inmate healthcare. The Supreme Court's decision will directly influence the scope of medical and social accommodations available to transgender inmates within federal correctional facilities, potentially setting a significant precedent for future cases.

The Trump administration initially adopted the new policy earlier this year. Its genesis can be traced back to a February 2025 policy, which itself was designed to implement an executive order signed by President Donald Trump shortly after his second inauguration. That executive order explicitly directed the attorney general to "ensure that no Federal funds are expended for any medical procedure, treatment, or drug for the purpose of conforming an inmate’s appearance to that of the opposite sex."

Subsequently, when the BOP formally adopted its February 2026 policy, it asserted that this action was taken "independently of" President Trump's February 2025 executive order. To support this significant shift in policy, the BOP provided an extensive administrative record, alongside a detailed 43-page memorandum. This documentation aimed to justify the changes from its previous guidelines.

In its accompanying memorandum, the Federal Bureau of Prisons attributed the policy alteration, among other factors, to what it described as "the latest scientific information." This justification marked a departure from the BOP's earlier policies, which had historically relied on recommendations from the World Professional Association for Transgender Health (WPATH) for guiding transgender inmate healthcare. The new policy effectively moves away from these established WPATH standards.

Li Nowlin-Sohl's argument to the Supreme Court underscores the profound impact of this policy, framing it as an attempt to overturn decades of established practice in federal prisons regarding transgender care. The challenge highlights a fundamental disagreement over the appropriate medical and social standards for supporting transgender individuals in correctional settings, particularly concerning access to hormone therapy and other forms of gender affirmation.

The Supreme Court's engagement with this case underscores the critical nature of the legal and ethical considerations surrounding transgender rights in federal prisons. A decision to allow the Trump administration's policy to proceed would significantly curtail the medical and social support available to transgender inmates, potentially impacting their health and well-being. Conversely, upholding the injunction would reinforce the existing framework for care.

Lawyers representing individuals in federal custody or civil rights organizations should closely monitor the Supreme Court's decision, as it will directly impact the scope of medical and social accommodations available to transgender inmates and could set a precedent for similar cases. This federal Bureau of Prisons transgender policy challenge represents a pivotal moment in the ongoing discourse surrounding healthcare access and human rights within the correctional system, particularly concerning the Trump executive order transgender care directives.

This development signals ongoing legal challenges to federal correctional policies concerning transgender inmate healthcare. Lawyers representing individuals in federal custody or civil rights organizations should monitor the Supreme Court's decision, as it will directly impact the scope of medical and social accommodations available to transgender inmates and could set a precedent for similar cases.

Source: Original reporting via Legal News Wire